AAA
IMGN

Affinity Asset Advisors’s Immunogen Inc IMGN Stock Holding History

Affinity Asset Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,404,608
Closed -$41.6M – 120
2023
Q4 		$41.6M Buy
+1,404,608
New +$28M 7.61% 1

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Affinity Asset Advisors's IMGN Position: Q1 2024 in Review

Affinity Asset Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,404,608 shares — an estimated $41.6M sold.

Affinity Asset Advisors first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $41.6M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Affinity Asset Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Affinity Asset Advisors sold 1,404,608 Immunogen Inc shares in Q1 2024, an estimated $41.6M.
  • Affinity Asset Advisors first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Affinity Asset Advisors's Immunogen Inc position peaked at $41.6M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Affinity Asset Advisors's 13F filing for Q1 2024, filed 14 May 2024.